BBI-5006

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBBI-5006
Drug Alias NamePDGFR alpha inhibitor (Boston Biomedical)BBI-5006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor alpha inhibitors
TargetsPlatelet-derived growth factor receptor alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Biomedical Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A